Insider Sale: EVP, Group Benefits Christopher Pyne Sells 4,500 Shares of Unum Group (UNM)

In this article:

On May 7, 2024, Christopher Pyne, EVP, Group Benefits at Unum Group (NYSE:UNM), executed a sale of 4,500 shares of the company. The transaction was filed on the same day with the SEC. Over the past year, the insider has sold a total of 8,250 shares and has not made any purchases.

Unum Group (NYSE:UNM) is a provider of financial protection benefits in the United States and the United Kingdom. The company offers disability, life, accident, critical illness, dental, and vision coverage to protect individuals and their families.

On the date of the sale, shares of Unum Group were priced at $52.47. This pricing positions the company with a market cap of approximately $9.97 billion. The price-earnings ratio of the stock stands at 7.83, below both the industry median of 11.9 and the company's historical median.

The GF Value of Unum Group is calculated at $44.04, suggesting that with a current price of $52.47, the stock is Modestly Overvalued with a price-to-GF-Value ratio of 1.19.

Insider Sale: EVP, Group Benefits Christopher Pyne Sells 4,500 Shares of Unum Group (UNM)
Insider Sale: EVP, Group Benefits Christopher Pyne Sells 4,500 Shares of Unum Group (UNM)

Reviewing the insider transaction trends, there have been no insider purchases and 12 insider sales over the past year for Unum Group.

Insider Sale: EVP, Group Benefits Christopher Pyne Sells 4,500 Shares of Unum Group (UNM)
Insider Sale: EVP, Group Benefits Christopher Pyne Sells 4,500 Shares of Unum Group (UNM)

This recent transaction by Christopher Pyne continues the trend of insider sales at Unum Group, reflecting a consistent pattern of stock disposals by insiders over the past year.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.

Advertisement